From: The effectiveness of NEPA in the prevention of chemotherapy-induced nausea vomiting among chemo naive patients in an Indian setting
Phases
Complete protection (%)
Enrolled patients (n = 329)
HEC (n = 260)
MEC (n = 69)
Acute phase
88.44
85.76
98.55
Delayed phase
81.76
81.15
84.05
Overall phase
80.54
79.61